Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
drug and medical device clinical development
Primary IR Contact
Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
Phone: +1.513.579.9911


Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.

MEDP (Common Stock)
Change (%)  +0.55 (1.55%)
Volume 101,363
Date as of  02/24/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Stock chart for: MEDP.O.  Currently trading at $36.11 with a 52 week high of $38.94 and a 52 week low of $26.51.

Upcoming Events

Tuesday, February 28, 2017 9:00 a.m. ETQ4 2016 Medpace Holdings, Inc. Earnings Conference Call

View all events